The ADNI Publication Policy: Commensurate recognition of critical contributors who are not authors

Orest Hurko; Sandra E. Black; Rachelle Doody; P. Murali Doraiswamy; Anthony Gamst; Jeffrey Kaye; Thomas O. Obisesan; Henry Rusinek; Doug Scharre; Reisa Sperling; Michael W. Weiner; Robert C. Green

doi:10.1016/j.neuroimage.2011.10.085

The ADNI Publication Policy: Commensurate recognition of critical contributors who are not authors

Orest Hurko, Sandra E. Black, Rachelle Doody, P. Murali Doraiswamy, Anthony Gamst, Jeffrey Kaye, Thomas O. Obisesan, Henry Rusinek, Doug Scharre, Reisa Sperling, Michael W. Weiner, Robert C. Green

Neurology

Research output: Contribution to journal › Comment/debate › peer-review

5 Scopus citations

Abstract

An efficient approach to certain types of biomedical research requires a scale that precludes involvement of all critical contributors in all aspects of experimental design, execution, and as well as writing of most, if not all, derived works. Guarantors of both the integrity of the data and of its subsequent analyses are required. When separate groups are responsible for each of these activities, each should be readily identifiable both in the primary publication and in all subsequent citations. We describe the publication policy of the Alzheimer Disease Neuroimaging Initiative (ADNI), its origins and its acceptance by the editorial and scientific communities.

Original language	English (US)
Pages (from-to)	4196-4200
Number of pages	5
Journal	NeuroImage
Volume	59
Issue number	4
DOIs	https://doi.org/10.1016/j.neuroimage.2011.10.085
State	Published - Feb 15 2012

ASJC Scopus subject areas

Neurology
Cognitive Neuroscience

Access to Document

10.1016/j.neuroimage.2011.10.085

Fingerprint Dive into the research topics of 'The ADNI Publication Policy: Commensurate recognition of critical contributors who are not authors'. Together they form a unique fingerprint.

Cite this

The ADNI Publication Policy : Commensurate recognition of critical contributors who are not authors. / Hurko, Orest; Black, Sandra E.; Doody, Rachelle; Doraiswamy, P. Murali; Gamst, Anthony; Kaye, Jeffrey; Obisesan, Thomas O.; Rusinek, Henry; Scharre, Doug; Sperling, Reisa; Weiner, Michael W.; Green, Robert C.

In: NeuroImage, Vol. 59, No. 4, 15.02.2012, p. 4196-4200.

Research output: Contribution to journal › Comment/debate › peer-review

Hurko, Orest ; Black, Sandra E. ; Doody, Rachelle ; Doraiswamy, P. Murali ; Gamst, Anthony ; Kaye, Jeffrey ; Obisesan, Thomas O. ; Rusinek, Henry ; Scharre, Doug ; Sperling, Reisa ; Weiner, Michael W. ; Green, Robert C. / The ADNI Publication Policy : Commensurate recognition of critical contributors who are not authors. In: NeuroImage. 2012 ; Vol. 59, No. 4. pp. 4196-4200.

@article{69b455796de4420887844872a41c5c8f,

title = "The ADNI Publication Policy: Commensurate recognition of critical contributors who are not authors",

abstract = "An efficient approach to certain types of biomedical research requires a scale that precludes involvement of all critical contributors in all aspects of experimental design, execution, and as well as writing of most, if not all, derived works. Guarantors of both the integrity of the data and of its subsequent analyses are required. When separate groups are responsible for each of these activities, each should be readily identifiable both in the primary publication and in all subsequent citations. We describe the publication policy of the Alzheimer Disease Neuroimaging Initiative (ADNI), its origins and its acceptance by the editorial and scientific communities.",

author = "Orest Hurko and Black, {Sandra E.} and Rachelle Doody and Doraiswamy, {P. Murali} and Anthony Gamst and Jeffrey Kaye and Obisesan, {Thomas O.} and Henry Rusinek and Doug Scharre and Reisa Sperling and Weiner, {Michael W.} and Green, {Robert C.}",

note = "Funding Information: Sandra Black has received contract research funds from Novartis Pharmaceuticals, Pfizer, Roche, GlaxoSmithKline; she had also chaired a Drug Safety Monitoring Board for a Pfizer tria; received speaker honoraria from Novartis Pharmaceuticals, Pfizer, and Eisa as well as honoraria for consulting from Pfizer, Novartis Pharmaceuticals, GlaxoSmithKline and Bristol‐Myers Squibb. None of these pertained to imaging work. ",

year = "2012",

month = feb,

day = "15",

doi = "10.1016/j.neuroimage.2011.10.085",

language = "English (US)",

volume = "59",

pages = "4196--4200",

journal = "NeuroImage",

issn = "1053-8119",

publisher = "Academic Press Inc.",

number = "4",

}

TY - JOUR

T1 - The ADNI Publication Policy

T2 - Commensurate recognition of critical contributors who are not authors

AU - Hurko, Orest

AU - Black, Sandra E.

AU - Doody, Rachelle

AU - Doraiswamy, P. Murali

AU - Gamst, Anthony

AU - Kaye, Jeffrey

AU - Obisesan, Thomas O.

AU - Rusinek, Henry

AU - Scharre, Doug

AU - Sperling, Reisa

AU - Weiner, Michael W.

AU - Green, Robert C.

N1 - Funding Information: Sandra Black has received contract research funds from Novartis Pharmaceuticals, Pfizer, Roche, GlaxoSmithKline; she had also chaired a Drug Safety Monitoring Board for a Pfizer tria; received speaker honoraria from Novartis Pharmaceuticals, Pfizer, and Eisa as well as honoraria for consulting from Pfizer, Novartis Pharmaceuticals, GlaxoSmithKline and Bristol‐Myers Squibb. None of these pertained to imaging work.

PY - 2012/2/15

Y1 - 2012/2/15

N2 - An efficient approach to certain types of biomedical research requires a scale that precludes involvement of all critical contributors in all aspects of experimental design, execution, and as well as writing of most, if not all, derived works. Guarantors of both the integrity of the data and of its subsequent analyses are required. When separate groups are responsible for each of these activities, each should be readily identifiable both in the primary publication and in all subsequent citations. We describe the publication policy of the Alzheimer Disease Neuroimaging Initiative (ADNI), its origins and its acceptance by the editorial and scientific communities.

AB - An efficient approach to certain types of biomedical research requires a scale that precludes involvement of all critical contributors in all aspects of experimental design, execution, and as well as writing of most, if not all, derived works. Guarantors of both the integrity of the data and of its subsequent analyses are required. When separate groups are responsible for each of these activities, each should be readily identifiable both in the primary publication and in all subsequent citations. We describe the publication policy of the Alzheimer Disease Neuroimaging Initiative (ADNI), its origins and its acceptance by the editorial and scientific communities.

UR - http://www.scopus.com/inward/record.url?scp=84857029603&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84857029603&partnerID=8YFLogxK

U2 - 10.1016/j.neuroimage.2011.10.085

DO - 10.1016/j.neuroimage.2011.10.085

M3 - Comment/debate

C2 - 22100665

AN - SCOPUS:84857029603

VL - 59

SP - 4196

EP - 4200

JO - NeuroImage

JF - NeuroImage

SN - 1053-8119

IS - 4

ER -

The ADNI Publication Policy: Commensurate recognition of critical contributors who are not authors

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this